Comparison of three antithrombotic strategies for emergent carotid stenting during stroke thrombectomy: a multicenter study.

Date publication

février 2023

Journal

Journal of neurointerventional surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Dr MANGIN Pierre

Tous les auteurs :
Pop R, Burel J, Finitsis SN, Papagiannaki C, Severac F, Mangin PH, Mihoc D, Leonard-Lorant I, Gheoca R, Wolff V, Chibbaro S, Sibon I, Richard S, Beaujeux R, Marnat G, Gory B

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/36759180

Résumé

Periprocedural antithrombotic treatment is a key determinant for the risk-benefit balance of emergent carotid artery stenting (eCAS) during stroke thrombectomy. We aimed to assess the safety and efficacy of three types of antithrombotic treatment.

Mots clés

Cervical, Platelets, Stent, Stroke, Thrombectomy

Référence

J Neurointerv Surg. 2023 02 9;: